• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Poll: What Is the Best Way to Improve Biosimilar Access?


Opinions are diverse on how best to clear the obstructions to biosimilar market entry and patient access.

Which of the following would best alleviate bottlenecks in biosimilar access?

A broader selection of biosimilars for each drug category
Improved physician training on biosimilar equivalence
Step therapy policies that promote the use of economical therapies
Mandatory biologics pricing disclosures by health plans
Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.